Skip to content

T-116_Procera-Bridge Zirconia - A Clinical Study

Procera-Bridge Zirconia - A Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02186808
Enrollment
80
Registered
2014-07-10
Start date
2005-05-31
Completion date
2015-04-30
Last updated
2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial Edentulism

Brief summary

The objective of the study is to evaluate the clinical performance of Procera® Bridge Zirconia veneered with NobelRondo Zirconia.

Detailed description

The study was designed to be an open, 5-year, prospective, multi-center clinical post-market study. The objectives of this clinical study were that industrial centrally produced 3- or 4-unit bridges of yttrium-oxide partially-stabilized (Y-TZP) zirconia (Procera Zirconia) in combination with the veneering ceramic material NobelRondo will show sufficient CDA ratings (90% R+S) and a sufficient survival rate after 1 and 5 years.

Interventions

DEVICEProcera® Bridge Zirconia

Patients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible.

Sponsors

Nobel Biocare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible * Indication: same indication as for metal supported bridges * Obtained informed consent from the patient

Exclusion criteria

* Currently known alcohol, drug or medication abuse, judged by the investigator, which might influence the follow-up program * Patients where a bridge part connection area of 3 mm of diameter is not possible to obtain (short clinical crowns) * Mobility of the abutment teeth exceeding grade I * Patients with pathologic pocket formation at abutment teeth * Patients with complete dentures in the opposing jaw * Patients with a removable partial denture in the same jaw

Design outcomes

Primary

MeasureTime frameDescription
Success Rate of Bridge Procera Bridge Zirconiaprosthesis delivery, 1 yearThe CDA index (1) is Romeo or Sierra at delivery and remains so up to 1 year post loading.

Secondary

MeasureTime frameDescription
Success Rate of Bridge Procera Bridge Zirconiaprosthesis delivery, 5 yearsThe CDA index (1) is Romeo or Sierra at delivery and remains so 5 year post loading.

Participant flow

Participants by arm

ArmCount
Procera® Bridge Zirconia
Patients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible. Procera® Bridge Zirconia: Patients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible.
80
Total80

Baseline characteristics

CharacteristicProcera® Bridge Zirconia
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
9 Participants
Age, Categorical
Between 18 and 65 years
71 Participants
Sex: Female, Male
Female
48 Participants
Sex: Female, Male
Male
32 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
38 / 80
serious
Total, serious adverse events
3 / 80

Outcome results

Primary

Success Rate of Bridge Procera Bridge Zirconia

The CDA index (1) is Romeo or Sierra at delivery and remains so up to 1 year post loading.

Time frame: prosthesis delivery, 1 year

Population: 78 patients were treated in total. 4 of the patients received two bridges (which is complaint with the protocol). Therefore there are more bridges than patients.

ArmMeasureValue (NUMBER)
Procera® Bridge ZirconiaSuccess Rate of Bridge Procera Bridge Zirconia100 percentage of successful implants
p-value: <0.05Wilcoxon (Mann-Whitney)
Secondary

Success Rate of Bridge Procera Bridge Zirconia

The CDA index (1) is Romeo or Sierra at delivery and remains so 5 year post loading.

Time frame: prosthesis delivery, 5 years

Population: 5 year data. Not all initially treated patients could be followed over the 5 years.

ArmMeasureValue (NUMBER)
Procera® Bridge ZirconiaSuccess Rate of Bridge Procera Bridge Zirconia95.8 percentage of successful implants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026